GF Xinde

Activity from announced rounds

Activity in this selectionsigmas-group-d86ce0ca

GF Xinde is the investment-manager brand named in Degron and DeepCtrls financing histories.

Recorded funding activity

Degron develops molecular-glue medicines for previously difficult protein targets. DeepCtrls coordinates power, cooling and computing through physical AI. The recorded companies address different biological and industrial operating problems.

Sources
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$40M
1 disclosed · full round size, not this investor’s share

By stage

Series A1
Series B1

By primary sector

AI1
Biotech1

By country

China2

Rounds

2 in this selection
DeepCtrls

DeepCtrls uses physical AI to coordinate energy, cooling and computing operations in data centers and industrial facilities.

UndisclosedSeries B+
Participant
Degron Therapeutics

Develops molecular glue degrader medicines targeting previously undruggable proteins

$40MSeries A+
Role not disclosed